Literature DB >> 23062419

Lung cancer staging: pathology issues.

Gabriel L Sica1, Anthony A Gal.   

Abstract

The previous, 6th, American Joint Committee on Cancer and International Union Against Cancer Staging Manual classification of lung cancer was largely unchanged from 5th edition. However, the most recent, 7th, edition has significantly updated the tumor, node, metastasis classification of lung cancer with regards to the inclusion of additional size criteria for T stages and revision of the staging for multiple tumor nodules, and represents the most dramatic change in 30 years. The recommendations for this most recent edition of tumor, node, metastasis classification are derived from a systematic retrospective review of data from a multi-international/institutional database of lung cancers and also incorporate expert opinion, to revise and clarify various staging factors. This review will primarily focus on the pathologically relevant aspects of 7th edition of American Joint Committee on Cancer/International Union Against Cancer classification of lung cancer as well as briefly reviewing the new staging guidelines.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23062419     DOI: 10.1053/j.semdp.2012.06.001

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  4 in total

1.  Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer.

Authors:  Yunfei Liao; Jie Gu; Yongbing Wu; Xiang Long; D I Ge; Jianjun Xu; Jianyong Ding
Journal:  Oncol Lett       Date:  2016-04-19       Impact factor: 2.967

2.  Differential diagnosis and cancer staging of a unique case with multiple nodules in the lung - lung adenocarcinoma, metastasis of colon adenocarcinoma, and colon adenocarcinoma metastasizing to lung adenocarcinoma.

Authors:  Yun Bai; Jianxing Qiu; Xueqian Shang; Ping Liu; Ying Zhang; Ying Wang; Yan Xiong; Ting Li
Journal:  Thorac Cancer       Date:  2015-04-24       Impact factor: 3.500

3.  Ubiquitin ligase Cbl-b is involved in icotinib (BPI-2009H)-induced apoptosis and G1 phase arrest of EGFR mutation-positive non-small-cell lung cancer.

Authors:  Xiaodong Mu; Ye Zhang; Xiujuan Qu; Kezuo Hou; Jian Kang; Xuejun Hu; Yunpeng Liu
Journal:  Biomed Res Int       Date:  2013-03-19       Impact factor: 3.411

4.  Correlation between maximal tumor diameter of fresh pathology specimens and computed tomography images in lung adenocarcinoma.

Authors:  Chul Hwan Park; Tae Hoon Kim; Sungsoo Lee; Duk Hwan Moon; Heae Surng Park
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.